Fresenius SE & Co. (OTCMKTS:FSNUY) Stock Price Down 5.2% – Here’s Why

Posted by Caroline Horne on May 22nd, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares fell 5.2% on Friday . The stock traded as low as $11.22 and last traded at $11.22. 49,496 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 104,004 shares. The stock had previously closed at $11.84.

Analyst Ratings Changes

Several research firms have weighed in on FSNUY. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy”.

View Our Latest Research Report on Fresenius SE & Co.

Fresenius SE & Co. Stock Down 3.8%

The firm’s 50-day simple moving average is $12.52 and its two-hundred day simple moving average is $13.77. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32. The stock has a market cap of $25.65 billion, a price-to-earnings ratio of 15.18 and a beta of 0.68.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%.The business had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. On average, sell-side analysts expect that Fresenius SE & Co. will post 1.05 EPS for the current fiscal year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.